ANEW MEDICAL, INC. (OTC: LEAS), an early-stage biotechnology company focused on developing disruptive new therapies to treat age-related neurodegenerative diseases, previously announced that it has entered into a definitive business combination agreement with Redwoods Acquisition Corp. (NASDAQ: RWOD; "Redwoods"), a publicly traded special purpose acquisition company, or SPAC. ANEW MEDICAL (ANEW) currently has its common stock quoted on the OTC Markets under the symbol "LEAS".